Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer

2006 ◽  
Vol 93 (6) ◽  
pp. 707-712 ◽  
Author(s):  
A. Gil-Rendo ◽  
G. Zornoza ◽  
M. J. García-Velloso ◽  
F. M. Regueira ◽  
C. Beorlegui ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Positron Emission Tomography ◽  
Lymph Node ◽  
Sentinel Lymph Node ◽  
Lymph Node Biopsy ◽  
Emission Tomography ◽  
Fluorodeoxyglucose Positron Emission Tomography ◽  
Node Biopsy ◽  
Positron Emission ◽  
Fluorodeoxyglucose Positron Emission

scholarly journals Comparison between18F-Fluorodeoxyglucose Positron Emission Tomography and Sentinel Lymph Node Biopsy for Regional Lymph Nodal Staging in Patients with Melanoma: A Review of the Literature

2011 ◽  
Vol 2011 ◽  
pp. 1-5 ◽  
Author(s):  
Paoletta Mirk ◽  
Giorgio Treglia ◽  
Marco Salsano ◽  
Pietro Basile ◽  
Alessandro Giordano ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
Lymph Node ◽  
Fdg Pet ◽  
Lymph Node Biopsy ◽  
Emission Tomography ◽  
Fluorodeoxyglucose Positron Emission Tomography ◽  
Nodal Staging ◽  
Node Biopsy ◽  
Positron Emission ◽  
Fluorodeoxyglucose Positron Emission

Aim. to compare18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) to sentinel lymph node biopsy (SLNB) for regional lymph nodal staging in patients with melanoma.Methods. We performed a literature review discussing original articles which compared FDG-PET to SLNB for regional lymph nodal staging in patients with melanoma.Results and Conclusions. There is consensus in the literature that FDG-PET cannot replace SLNB for regional lymph nodal staging in patients with melanoma.

Sign in / Sign up

Export Citation Format

Share Document